Description
Tirzepatide is a synthetic peptide belonging to the dual incretin receptor agonist class. It is characterised by activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
LIFE supplies Tirzepatide 10 mg as a high-purity, lyophilised peptide for laboratory and analytical research. Each batch is accompanied by a Certificate of Analysis (COA), with additional independent laboratory verification available for selected batches.
Product characteristics
| Specification | Details |
| Product | Tirzepatide (LY3298176) |
| Quantity | 10 mg per vial |
| Form | Lyophilised powder |
| Purity | ≥99% (HPLC) |
| Molecular weight | 4813.45 g/mol |
| Molecular formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Research category | Dual GIP/GLP-1 receptor agonist |
| Storage | Refrigerated at 2–8°C |
| Intended application | Laboratory and analytical research |
Quality control
LIFE Tirzepatide 10 mg is supplied with batch-specific analytical documentation. The current batch has undergone additional independent verification by Janoshik Analytical.
| Test information | Result |
|---|---|
| Batch | TR10-260423 |
| Internal HPLC purity | 99.13% |
| Independent HPLC purity | 99.62% |
| Independent laboratory | Janoshik Analytical |
View Independent Laboratory Report
Further information
For a comparison of related compounds and their receptor profiles, see our Retatrutide vs Tirzepatide research comparison.
For general laboratory preparation and handling, consult our Peptide Reconstitution Guide.
Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.
